Search results for "load"

showing 10 items of 1967 documents

Optimal therapy in hepatitis C virus genotypes 2 and 3 patients

2011

Current guidelines recommend that patients with genotype 2 (G2) and 3 (G3) chronic hepatitis C be treated with pegylated interferon (PEG-IFN) plus low doses of ribavirin (800 mg/day) for 24 weeks, resulting in a sustained virological response (SVR) rate of approximately 80%. Considering these high response rates, several recent randomized trials have assessed whether shorter treatment (12–16 weeks) could be cost-effective in these patients. The results of these studies vary but suggest better responsiveness in G2 patients, and overall, do not strongly support reducing treatment to o 24 weeks in all patients. On the other hand, the presence of a rapid virological response (RVR) (defined as a…

medicine.medical_specialtyHepatologyCombination therapybusiness.industryRibavirinHepatitis C virusHepatitis Cmedicine.diseasemedicine.disease_causeGastroenterologySurgerylaw.inventionchemistry.chemical_compoundchemistryRandomized controlled trialPegylated interferonlawInterferonInternal medicinemedicinebusinessViral loadmedicine.drugLiver International
researchProduct

Optimized threshold for serum HCV RNA to predict treatment outcomes in hepatitis C patients receiving peginterferon alfa-2a/ribavirin

2012

Summary.  It is unclear whether the current threshold for ‘high’ hepatitis C virus (HCV) RNA level (800 000 IU/mL) is optimal for predicting sustained virological response (SVR). We retrospectively analysed pretreatment HCV RNA levels and SVR rates in 1529 mono-infected and 176 HIV–HCV co-infected patients treated with peginterferon alfa-2a (40 kD) plus ribavirin. We improved the threshold for differentiating low and high viral load by fitting semiparametric generalized additive logistic regression models to the data and constructing receiver operating characteristics curves. Among HCV genotype 1 mono-infected patients, the difference in SVR rates between those with low and high baseline HC…

medicine.medical_specialtyHepatologyReceiver operating characteristicbusiness.industryRibavirinHepatitis C virusvirus diseasesHepatitis Cmedicine.diseaseLogistic regressionmedicine.disease_causeGastroenterologydigestive system diseaseschemistry.chemical_compoundInfectious DiseaseschemistryVirologyInternal medicineGenotypeImmunologymedicinebusinessViral loadPeginterferon alfa-2amedicine.drugJournal of Viral Hepatitis
researchProduct

HCV E1E 2‐ MF 59 vaccine in chronic hepatitis C patients treated with PEG ‐ IFN α2a and R ibavirin: a randomized controlled trial

2013

Hepatitis C virus (HCV) vaccines may be able to increase viral clearance in combination with antiviral therapy. We analysed viral dynamics and HCV-specific immune response during retreatment for experienced patients in a phase Ib study with E1E2MF59 vaccine. Seventy-eight genotype 1a/1b patients [relapsers (30), partial responders (16) and nonresponders (32) to interferon-(IFN)/ribavirin-(RBV)] were randomly assigned to vaccine (V:23), Peg-IFNα2a-180-ug/qw and ribavirin 1000-1200-mg/qd for 48 weeks (P/R:25), or their combination (P/R + V:30). Vaccine (100 μg/0.5 mL) was administered intramuscularly at week 0-4-8-12-24-28-32-36. Neutralizing of binding (NOB) antibodies and lymphocyte prolife…

medicine.medical_specialtyHepatologybiologybusiness.industryT cellHepatitis C virusRibavirinmedicine.disease_causeVirologyGastroenterologyVaccinationchemistry.chemical_compoundInfectious Diseasesmedicine.anatomical_structurechemistryInterferonVirologyInternal medicinePEG ratiomedicinebiology.proteinAntibodybusinessViral loadmedicine.drugJournal of Viral Hepatitis
researchProduct

Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: The HEPAIG study

2010

Acute hepatitis C continues to be a concern in men who have sex with men (MSM), and its optimal management has yet to be established. In this study, the clinical, biological, and therapeutic data of 53 human immunodeficiency virus (HIV)-infected MSM included in a multicenter prospective study on acute hepatitis C in 2006-2007 were retrospectively collected and analyzed. The mean hepatitis C virus (HCV) viral load at diagnosis was 5.8 ± 1.1 log10 IU/mL (genotype 4, n = 28; genotype 1, n = 14, genotype 3, n = 7). The cumulative rates of spontaneous HCV clearance were 11.0% and 16.5% 3 and 6 months after diagnosis, respectively. Forty patients were treated, 38 of whom received pegylated interf…

medicine.medical_specialtyHepatologybusiness.industryRibavirinHepatitis C virusvirus diseasesHepatitis CHepatologymedicine.diseasemedicine.disease_causeGastroenterologydigestive system diseasesMen who have sex with menchemistry.chemical_compoundchemistryPegylated interferonInternal medicineImmunologymedicineProspective cohort studybusinessViral loadmedicine.drugHepatology
researchProduct

Hormonal and nutritional control of L‐carnitine uptake in myoblastic C2C12 cells

2008

L-Carnitine plays an important role in skeletal muscle bioenergetics, and its bioavailability and thus its import may be crucial for muscle function. We studied the effect of thyroid hormone, insulin, and iron overload, hormones and nutrients known to alter muscle metabolism, on L-carnitine import into C2C12 cells. We report here L-carnitine uptake is increased by thyroid hormones and decreased by iron. Insulin was found to be ineffective in altering the L-carnitine uptake.

medicine.medical_specialtyIron OverloadOrganic Cation Transport ProteinsBioenergeticsPhysiologymedicine.medical_treatmentBiologyCell LineCellular and Molecular NeuroscienceCarnitinePhysiology (medical)Internal medicinemedicineHumansInsulinNutritional Physiological PhenomenaRNA MessengerCarnitineMuscle SkeletalSolute Carrier Family 22 Member 5InsulinThyroidSkeletal muscleMetabolismBlotting NorthernHormonesmedicine.anatomical_structureEndocrinologyTriiodothyronineNeurology (clinical)Iron CompoundsEndocrine glandHormonemedicine.drugMuscle & Nerve
researchProduct

Antiviral triple therapy with boceprevir in a chronic hepatitis C haemodialysis patient awaiting kidney re-transplantation

2014

medicine.medical_specialtyKidneyHepatologyRe transplantationbusiness.industryGastroenterologyMEDLINEHepatitis Cmedicine.diseaseGastroenterologychemistry.chemical_compoundmedicine.anatomical_structurePharmacotherapychemistryInternal medicineBoceprevirmedicinebusinessViral loadKidney transplantationDigestive and Liver Disease
researchProduct

Pharmacokinetics of anidulafungin during albumin dialysis

2014

In the ICU setting, current guidelines recommend echi-nocandins as the first-line treatment for invasive candi-diasis [1]. Albumin dialysis (AD) has been used in theICU as supportive therapy for hepatic failure, but thistechnique can significantly enhance drug elimination [2].We prescribed anidulafungin for suspected invasivecandidiasis in a patient with severe liver failure treatedwith AD and measured the plasma concentrations of thedrug using high-performance liquid chromatography.This study (GEF-ANI-2010-02) was approved by thelocal ethics committee (INCLIVA, Institute of Research,Valencia, Spain) and written informed consent wasobtained from the patient’s next of kin. An adult patientwa…

medicine.medical_specialtyLetterbusiness.industrymedicine.medical_treatmentAlbuminUrineCritical Care and Intensive Care MedicineLoading doseSurgeryPharmacokineticsAnesthesiamedicineAnidulafunginLiver functionHepatectomybusinessDialysismedicine.drugCritical Care
researchProduct

Need to evaluate the performance of real-time PCR assays for the quantitation of cytomegalovirus DNA load in lower respiratory tract specimens

2013

There is an increasing appreciation for the potential clinical value of the quantitation of cytomegalovirus (CMV) DNA in the lower respiratory tract in critically ill patients lacking canonical immunosuppression, in view of the possible pathogenic role of CMV in these patients [1]. No data have been published on the analytical performance of real-time PCR assays for this purpose. We present our data on the performance of the COBAS® AmpliPrep/COBAS® TaqMan CMV PCR Assay (Roche Diagnostics, Mannheim, Germany) for the quantitation of CMV DNA in tracheal aspirates (TA). This CMV PCR assay has been approved recently by the US Food and Drug Administration for use with plasma specimens [2]. We cho…

medicine.medical_specialtyLettermedicine.medical_treatmentCongenital cytomegalovirus infectionCytomegalovirusCritical Care and Intensive Care MedicineReal-Time Polymerase Chain ReactionGastroenterologySensitivity and SpecificityCytomegalovirus DNAInternal medicinemedicineTaqManHumansRespiratory Tract InfectionsMechanical ventilationRespiratory tract infectionsbusiness.industryViral Loadmedicine.diseaseVirologyRespiration ArtificialIntensive Care Unitsmedicine.anatomical_structureReal-time polymerase chain reactionCytomegalovirus InfectionsDNA ViralbusinessViral loadRespiratory tract
researchProduct

Similar biomechanical properties of four tripled tendon graft models for ACL reconstruction

2021

Abstract Purpose The present study tested and compared the biomechanical properties of four different triplicate graft tendon techniques. Methods 32 tripled tendons from the common extensor muscle of bovine fingers were tested on a material testing machine, passing the end loop over a metal rod of a clevis connected to the load cell on the upper side, and fixing the lower end to a clamp. The samples were divided into four groups: (A) tripled with a free end sutured only to one of the two fixed bundles (B) tripled with a free end positioned between the two fixed strands and sutured to both (C) tripled with an S-shape and all the three strands sutured together at the upper and lower extremiti…

medicine.medical_specialtyLoad cellTendonsGraftLoad to failureMaterials TestingMedicineAnimalsHumansOrthopedics and Sports MedicineAnterior Cruciate LigamentTendon graftOrthodonticsAnterior Cruciate Ligament Reconstructionbusiness.industryKnee biomechanicsSignificant differenceTripled graftBiomechanicsGeneral MedicineTendonBiomechanical PhenomenaACL reconstructionmedicine.anatomical_structureClampOrthopedic surgerySurgeryCattleGraft diameterbusinessTriplicate
researchProduct

Low-protein vegetarian diet does not have a short-term effect on blood acid–base status but raises oxygen consumption during submaximal cycling

2012

Abstract Background Acid–base balance refers to the equilibrium between acids and bases in the human body. Nutrition may affect acid–base balance and further physical performance. With the help of PRAL (potential renal acid load), a low-protein vegetarian diet (LPVD) was designed to enhance the production of bases in body. The aim of this study was to investigate if LPVD has an effect on blood acid–base status and performance during submaximal and maximal aerobic cycling. Methods Nine healthy, recreationally active men (age 23.5 ± 3.4 yr) participated in the study and were randomly divided into two groups in a cross-over study design. Group 1 followed LPVD for 4 days and group 2 ate normall…

medicine.medical_specialtyLow proteinAcid–base balancechemistry.chemical_elementlcsh:TX341-641Clinical nutritionAcid–base homeostasisOxygenMedicineTerm effectFood sciencelcsh:Sports medicineNutritionNutrition and Dieteticsbusiness.industryAerobic performanceAcid loadchemistryPhysical therapyAcid–base reactionlcsh:RC1200-1245businessCyclinglcsh:Nutrition. Foods and food supplyFood ScienceResearch ArticleJournal of the International Society of Sports Nutrition
researchProduct